| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1529-0131(200101)44:1<13::AID-ANR3>3.0.CO;2-6 |
| P698 | PubMed publication ID | 11212151 |
| P2093 | author name string | Weyand CM | |
| Takemura S | |||
| Goronzy JJ | |||
| Warrington KJ | |||
| P2860 | cites work | A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation | Q24317089 |
| The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
| Phenotypic and functional analysis of CD4+ NKRP1A+ human T lymphocytes. Direct evidence that the NKRP1A molecule is involved in transendothelial migration | Q28252245 | ||
| Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors | Q28259065 | ||
| Natural killer cell activation and inhibition by receptors for MHC class I. | Q33664740 | ||
| HLA polymorphisms and T cells in rheumatoid arthritis | Q33805889 | ||
| T cell homeostasis in patients with rheumatoid arthritis | Q35200330 | ||
| Perturbation of the T cell repertoire in rheumatoid arthritis | Q36735976 | ||
| CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity | Q37354502 | ||
| High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. | Q37382323 | ||
| Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking | Q41202614 | ||
| Emergence of oligoclonal T cell populations following therapeutic T cell depletion in rheumatoid arthritis | Q41304856 | ||
| Expansion of unusual CD4+ T cells in severe rheumatoid arthritis | Q41496871 | ||
| B-cell activation and development within chronically inflamed synovium in rheumatoid and reactive arthritis | Q41544780 | ||
| Intra-epithelial lymphocytes. Evidence for regional specialization and extrathymic T cell maturation in the human gut epithelium | Q41658959 | ||
| Dynamics of fine T-cell subsets during HIV disease and after thymic ablation by mediastinal irradiation | Q41665949 | ||
| HIV-1-induced thymocyte depletion is associated with indirect cytopathicity and infection of progenitor cells in vivo | Q46062714 | ||
| NK cell receptors | Q46858751 | ||
| Natural killer cell receptors | Q47933744 | ||
| Abnormality of Leu 2+7+ cells in acquired immune deficiency syndrome (AIDS), AIDS-related complex, and asymptomatic homosexuals. | Q55243545 | ||
| Killer Cell Activating Receptors Function as Costimulatory Molecules on CD4+CD28null T Cells Clonally Expanded in Rheumatoid Arthritis | Q56607491 | ||
| Pure Red-Cell Aplasia Associated with Clonal Expansion of Granular Lymphocytes Expressing Killer-Cell Inhibitory Receptors | Q56795517 | ||
| Immunogenetic similarities between patients with Felty's syndrome and those with clonal expansions of large granular lymphocytes in rheumatoid arthritis | Q57159087 | ||
| Differential expression of CD8α and CD8β associated with MHC-restricted and non-MHC-restricted cytolytic effector cells | Q58415226 | ||
| P433 | issue | 1 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 13-20 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Arthritis & Rheumatology | Q4797636 |
| P1476 | title | CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems | |
| P478 | volume | 44 |
| Q56902724 | Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus |
| Q57226743 | Activating NK-cell receptors co-stimulate CD4+CD28−T cells in patients with rheumatoid arthritis |
| Q93274017 | Activation of miR-21-Regulated Pathways in Immune Aging Selects against Signatures Characteristic of Memory T Cells |
| Q40398975 | Aging of the Immune System. Mechanisms and Therapeutic Targets |
| Q24797866 | Aging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity - catalysts of autoimmunity and chronic inflammation |
| Q30400692 | An approach to the immunophenotypic features of circulating CD4⁺NKG2D⁺ T cells in invasive cervical carcinoma |
| Q89983758 | Association of MICA-129Met/Val polymorphism with clinical outcome of anti-TNF therapy and MICA serum levels in patients with rheumatoid arthritis |
| Q50915395 | Autoimmune arthritis induces paired immunoglobulin-like receptor B expression on CD4+ T cells from SKG mice. |
| Q24813041 | Between adaptive and innate immunity: TLR4-mediated perforin production by CD28null T-helper cells in ankylosing spondylitis |
| Q64054989 | CD28 CD4 T-cell expansions in autoimmune disease suggest a link with cytomegalovirus infection |
| Q55511972 | CD4+CD28null T Lymphocytes are Associated with the Development of Atrial Fibrillation after Elective Cardiac Surgery. |
| Q34546418 | CD8+CD28- T cells: certainties and uncertainties of a prevalent human T-cell subset |
| Q48177039 | Can we talk about CD4+CD28- lymphocytes as a risk factor for ischemic stroke? |
| Q36176981 | Chronic inflammation and aging: DNA damage tips the balance |
| Q51313776 | Circulating IL-27 Is Elevated in Rheumatoid Arthritis Patients. |
| Q41330684 | Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation |
| Q39283173 | Cytotoxic lymphocytes and atherosclerosis: significance, mechanisms and therapeutic challenges |
| Q42363315 | Deficient Activity of the Nuclease MRE11A Induces T Cell Aging and Promotes Arthritogenic Effector Functions in Patients with Rheumatoid Arthritis. |
| Q36252156 | Diagnostic and prognostic potential of gene microarrays in rheumatoid arthritis |
| Q34079261 | Differential expression of NK receptors CD94 and NKG2A by T cells in rheumatoid arthritis patients in remission compared to active disease. |
| Q33411566 | Disease-associated pathophysiologic structures in pediatric rheumatic diseases show characteristics of scale-free networks seen in physiologic systems: implications for pathogenesis and treatment |
| Q40428698 | Distinct transcriptional control mechanisms of killer immunoglobulin-like receptors in natural killer (NK) and in T cells |
| Q44461967 | Diversity of killer cell immunoglobulin-like receptor genes in the Bai ethnic minority of Yunnan, China |
| Q89278064 | Epigenetics of T cell aging |
| Q81155956 | Flow cytometric analysis of human antigen-specific T-cell proliferation |
| Q39275481 | Follicular helper T cells in the pathogenesis of IgG4-related disease. |
| Q40735567 | Functional modulation of expanded CD8+ synovial fluid T cells by NK cell receptor expression in HLA-B27-associated reactive arthritis. |
| Q46218661 | Genetic polymorphism analysis of killer cell immunoglobulin-like receptor genes in the Chinese Uygur population |
| Q64105803 | HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke |
| Q61711484 | Human CD4low CD25high regulatory T cells indiscriminately kill autologous activated T cells |
| Q44454214 | Imbalance of peripheral B lymphocytes and NK cells in rheumatoid arthritis. |
| Q34777989 | Immune aging and autoimmunity |
| Q39903023 | Immune-mediated pore-forming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis. |
| Q40262272 | Immunogenetic factors determining the evolution of T-cell large granular lymphocyte leukaemia and associated cytopenias. |
| Q35198258 | Immunosenescence, autoimmunity, and rheumatoid arthritis |
| Q49693642 | Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis |
| Q77628789 | Involvement of CD4+,CD57+ T cells in the disease activity of rheumatoid arthritis |
| Q28202653 | Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis |
| Q38310372 | Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility. |
| Q53674067 | Killer cell immunoglobulin receptor profile on CD4(+) CD28(-) T cells and their pathogenic role in non-dialysis-dependent and dialysis-dependent chronic kidney disease patients. |
| Q87407173 | Killer-cell immunoglobulin-like receptor expression on lymphocyte subsets in multiple sclerosis patients treated with interferon-β: evaluation as biomarkers for clinical response |
| Q38676903 | Lymphocytes as Biomarkers of Therapeutic Response in Rheumatic Autoimmune Diseases, Is It a Realistic Goal? |
| Q64108180 | Mesenchymal Stem Cells Improve Rheumatoid Arthritis Progression by Controlling Memory T Cell Response |
| Q41159159 | Minimal hepatic encephalopathy is associated with expansion and activation of CD4+CD28-, Th22 and Tfh and B lymphocytes |
| Q58549284 | Mixed-effects association of single cells identifies an expanded effector CD4 T cell subset in rheumatoid arthritis |
| Q42020570 | NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab |
| Q36543814 | NK cell receptors as tools in cancer immunotherapy. |
| Q52576677 | NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis. |
| Q34124327 | Natural killer cell immunoglobulin-like receptor (KIR) locus profiles in African and South Asian populations |
| Q24793284 | Natural killer cells and autoimmunity |
| Q41111557 | New perspectives on the ligands and function of the killer cell immunoglobulin-like receptor KIR3DL2 in health and disease |
| Q37710757 | Novel Senescent Regulatory T-Cell Subset with Impaired Suppressive Function in Rheumatoid Arthritis. |
| Q24792928 | Novel approaches to gene expression analysis of active polyarticular juvenile rheumatoid arthritis |
| Q35748061 | Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis |
| Q81640403 | Persistent oligoclonal CD4dimCD8+T cells in peripheral blood |
| Q35107187 | Premature CD4+ T cell aging and its contribution to lymphopenia-induced proliferation of memory cells in autoimmune-prone non-obese diabetic mice |
| Q37089409 | Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. |
| Q50875026 | Presence of more activating KIR genes is associated with Hashimoto's thyroiditis. |
| Q38463964 | Prevalence and clinical association of clonal T-cell expansions in Myelodysplastic Syndrome |
| Q24797697 | Prevalence, clinical relevance and characterization of circulating cytotoxic CD4+CD28- T cells in ankylosing spondylitis |
| Q39530138 | Relationship between NK Cell Activation and Clinical Response in Rheumatoid Arthritis Treated with Rituximab |
| Q33555281 | Rheumatoid Arthritis, Immunosenescence and the Hallmarks of Aging |
| Q24812262 | Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study |
| Q36370648 | Selective activation of the c-Jun NH2-terminal protein kinase signaling pathway by stimulatory KIR in the absence of KARAP/DAP12 in CD4+ T cells |
| Q50234923 | Senescent T-Cells Promote Bone Loss in Rheumatoid Arthritis |
| Q81210863 | Significance of unconventional peripheral CD4+CD8dim T cell subsets |
| Q36401840 | Skewed distribution of proinflammatory CD4+CD28null T cells in rheumatoid arthritis |
| Q39193878 | Successful and Maladaptive T Cell Aging |
| Q51818412 | T cell senescence and contraction of T cell repertoire diversity in patients with chronic obstructive pulmonary disease. |
| Q26859971 | T-cell aging in rheumatoid arthritis |
| Q36577464 | T-cell-targeted therapies in rheumatoid arthritis |
| Q36227892 | TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque |
| Q37689488 | Targeting cardiovascular risk in rheumatoid arthritis: a dual role for statins |
| Q36160188 | Targets of immune regeneration in rheumatoid arthritis |
| Q35806766 | Telomere dysfunction, autoimmunity and aging. |
| Q24804863 | The expansion of CD4+CD28- T cells in patients with rheumatoid arthritis |
| Q61945657 | The expansion of CD4+CD28− t cells in patients with chronic kidney graft rejection |
| Q103806791 | The immunology of rheumatoid arthritis |
| Q36898613 | The janus head of T cell aging - autoimmunity and immunodeficiency |
| Q38550407 | The life (and death) of CD4+ CD28(null) T cells in inflammatory diseases |
| Q42622426 | The potential importance of Toll-like receptors in ankylosing spondylitis |
| Q34790008 | The role of endothelial cell dysfunction in the cardiovascular mortality of RA. |
| Q28082856 | The story of CD4+ CD28- T cells revisited: solved or still ongoing? |
| Q53492117 | The tumour suppressor gene p53 modulates the severity of antigen-induced arthritis and the systemic immune response. |
| Q61946763 | Therapy with infliximab decreases the CD4+CD28? T cell compartment in peripheral blood in patients with rheumatoid arthritis |
| Q40558811 | Tumor necrosis factor-alpha and CD80 modulate CD28 expression through a similar mechanism of T-cell receptor-independent inhibition of transcription |
| Q33706812 | Unchecked CD70 expression on T cells lowers threshold for T cell activation in rheumatoid arthritis |
| Q38543383 | Understanding the major risk factors in the beginning and the progression of rheumatoid arthritis: current scenario and future prospects |
| Q37541433 | Unusual CD4+CD28- T Cells and Their Pathogenic Role in Chronic Inflammatory Disorders |
Search more.